Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 multicenter randomized double-blind three-arm trial of budesonide nasal spray for seasonal allergic rhinitis
CTR20251386Phase 3Completed
- Sponsor
- CF PharmTech
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in seasonal allergic rhinitis (SAR), perennial rhinitis, non-allergic rhinitis (NAR), sponsored by CF PharmTech. Started Apr 2025; status: completed.
02
Drugs
budesonide
03
Conditions
seasonal allergic rhinitis (SAR)perennial rhinitisnon-allergic rhinitis (NAR)
Beyond the preview
Go deeper on CTR20251386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251386.